Facon, T., Niesvizky, R., Mateos, M., Siegel, D., Rosenbaum, C., Bringhen, S., . . . Dimopoulos, M. A. (2020). Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma. Blood Adv.
Chicago-стиль цитированияFacon, Thierry, et al. "Efficacy and Safety of Carfilzomib-based Regimens in Frail Patients With Relapsed And/or Refractory Multiple Myeloma." Blood Adv 2020.
MLA-цитированиеFacon, Thierry, et al. "Efficacy and Safety of Carfilzomib-based Regimens in Frail Patients With Relapsed And/or Refractory Multiple Myeloma." Blood Adv 2020.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.